GlobeNewswire·May 14, 2026, 7:00 AM ET

Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance

First Quarter 2026 revenue was $647.9 million, representing a 15.9% increase over the prior year period.
First Quarter net income reached $41.7 million, compared to $5.2 million in the prior year.
Adjusted EBITDA for the quarter was $84.4 million, a 25.2% increase from the prior year.
Gross margin increased to $205.4 million (31.7% of revenue) from $183.6 million (32.8% of revenue) in the prior year.
Revenue growth was driven by increases in the PDS segment ($75.7 million), HHH segment ($9.9 million), and MS segment ($3.2 million).
Full Year 2026 revenue guidance was raised to $2.56–$2.58 billion from $2.54–$2.56 billion.
Full Year 2026 Adjusted EBITDA guidance was raised to $328–$332 million from $318–$322 million.
Cash on hand was $189.3 million as of April 4, 2026, with $110.0 million in incremental borrowing capacity under the securitization facility.
Total indebtedness stood at $1,483.4 million, with interest rate exposure hedged via swaps and caps.
Net cash provided by operating activities was $4.3 million, while free cash flow was negative $3.8 million for the quarter.
The company is finalizing regulatory approval for the Family First Homecare transaction.
Conference calls to discuss results are scheduled for May 14, 2026, at 10:00 a.m. Eastern Time.